S
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
Price:
1 542 JPY
Market Closed
Updated:
May 1, 2024
Shin Nippon Biomedical Laboratories Ltd
Net Income (Common)
|
Shin Nippon Biomedical Laboratories Ltd
Net Income (Common) Peer Comparison
Comparables:
2309
2370
4880
2183
7079
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
S
|
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
|
Net Income (Common)
¥5.5B
|
CAGR 3-Years
31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CMIC Holdings Co Ltd
TSE:2309
|
Net Income (Common)
¥5.3B
|
CAGR 3-Years
50%
|
CAGR 5-Years
29%
|
CAGR 10-Years
14%
|
|
|
Medinet Co Ltd
TSE:2370
|
Net Income (Common)
-¥1.4B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-11%
|
|
|
CellSource Co Ltd
TSE:4880
|
Net Income (Common)
¥923.1m
|
CAGR 3-Years
50%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
Linical Co Ltd
TSE:2183
|
Net Income (Common)
¥680.4m
|
CAGR 3-Years
41%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
4%
|
|
|
WDB coco Co Ltd
TSE:7079
|
Net Income (Common)
¥743.6m
|
CAGR 3-Years
34%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
See Also
What is Shin Nippon Biomedical Laboratories Ltd's Net Income (Common)?
Net Income (Common)
5.5B
JPY
5.5B
JPY
Based on the financial report for Dec 31, 2023, Shin Nippon Biomedical Laboratories Ltd's Net Income (Common) amounts to 5.5B JPY.
What is Shin Nippon Biomedical Laboratories Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
31%
31%
Over the last year, the Net Income (Common) growth was -12%. The average annual Net Income (Common) growth rates for Shin Nippon Biomedical Laboratories Ltd have been 31% over the past three years .
You don't have any saved screeners yet
